SUSMED, Inc. Stock Hits Day Low of JPY 657 Amid Price Pressure

SUSMED, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock hitting an intraday low of JPY 657.00. The company’s stock has declined by 13.8% on May 21, 2026, contrasting sharply with the Japan Nikkei 225, which has risen by 3.14% during the same period. Over the past week, SUSMED has seen a steep decline of 34.78%, and its performance over the last month is down by 30.46%. Year-to-date, the stock has dropped 21.56%, while its one-year performance shows a modest gain of 13.16%, significantly lagging behind the Nikkei 225's impressive 65.38% return. Financial metrics indicate challenges for SUSMED, including a low return on equity (ROE) of 0.04%, reflecting limited profitability. The company reported a net sales decline of 52.13% and a net profit loss of JPY 210.77 million, marking a staggering decrease of 1,149.8%. With a market capitalization of JPY 15,704 million, SUSMED continues to navigate a challenging landscape within its industry.